An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion.
Integrins, the major receptors for cell adhesion to the extracellular matrix, play important roles during tumor progression. However, it is still unclear whether genetic lesions that occur during carcinoma development can lead to altered integrin function, and how changes in integrin function contribute to subsequent carcinoma progression. Loss-of-function mutations in p53 and activating mutations in H-Ras, which immortalize and transform epithelial cells, respectively, are common causal events in squamous cell carcinoma (SCC). Phenotypes resulting from these two genetic lesions promote SCC progression and are, therefore, potential targets for anticancer therapies. We developed a model system of keratinocyte transformation that has allowed us to investigate the individual roles of p53 mutation and oncogenic Ras mutation in the acquisition of integrin alpha3beta1-regulated phenotypes that promote SCC progression. Using this model, we show that keratinocyte immortalization by p53-null mutation causes a switch in alpha3beta1 function that induces matrix metalloproteinase (MMP)-9 gene expression in tumorigenic cells. This acquired alpha3beta1-dependent regulation of MMP-9 was maintained during subsequent transformation by oncogenic Ras, and it promoted invasion of tumorigenic keratinocytes. Our results show that loss of p53 function leads to changes in integrin-mediated gene regulation that occur during SCC progression and play a critical role in tumor cell invasion.
Lamar
John M
JM
Center for Cell Biology and Cancer Research, Albany Medical College, Albany, New York 12208-3479, USA.
Pumiglia
Kevin M
KM
DiPersio
C Michael
CM
D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000201:enzymology / Q000235:genetics / Q000473:pathology*; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000378:metabolism / Q000473:pathology*; D002478:Cells, Cultured; D015870:Gene Expression; D006801:Humans; D039201:Integrin alpha3beta1 / Q000378:metabolism*; D015603:Keratinocytes / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism; D015854:Up-Regulation
D039201:Integrin alpha3beta1; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53; D020780:Matrix Metalloproteinase 9
J Dermatol Sci. 1998 May;17(1):1-7
9651822
Nat Cell Biol. 2000 Oct;2(10):737-44
11025665
J Urol. 1997 Jul;158(1):206-11
9186361
Science. 2002 Mar 29;295(5564):2387-92
11923519
Cancer Res. 1992 Mar 1;52(5):1336-41
1310643
Int J Cancer. 1994 Aug 15;58(4):488-91
8056444
Development. 1996 Nov;122(11):3537-47
8951069
J Cell Sci. 2004 Apr 1;117(Pt 9):1847-57
15075244
Curr Opin Cell Biol. 2000 Oct;12(5):548-53
10978888
J Invest Dermatol. 2008 Mar;128(3):575-86
17762853
Mol Biol Cell. 2007 Nov;18(11):4210-21
17699601
J Clin Invest. 2002 Apr;109(8):999-1006
11956235
Mol Carcinog. 2001 Jun;31(2):74-82
11429784
Int J Cancer. 2000 Aug 1;87(3):336-42
10897037
Nature. 1992 Mar 19;356(6366):215-21
1552940
Mol Cell Biol. 2003 Jul;23(14):4901-16
12832476
Mol Carcinog. 1998 Jan;21(1):50-61
9473771
Carcinogenesis. 2004 Jul;25(7):1137-47
15001536
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124-8
1946433
Oncogene. 2007 Apr 12;26(17):2407-22
17072348
Science. 1997 Jul 11;277(5323):225-8
9211848
Mol Biol Cell. 1999 Feb;10(2):407-16
9950685
Eur J Cancer B Oral Oncol. 1994 Sep;30B(5):338-45
7703804
J Invest Dermatol. 1993 Jun;100(6):746-8
8496613
Gynecol Oncol. 1999 Mar;72(3):380-6
10053110
Cancer Metastasis Rev. 2005 Sep;24(3):413-23
16258729
Mol Cell. 2007 Jun 8;26(5):745-52
17540599
Cell. 2000 Oct 27;103(3):481-90
11081634
Epithelial Cell Biol. 1993 Jan;2(1):26-43
8353592
Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5096-100
1711218
Am J Pathol. 2000 Dec;157(6):1777-83
11106549
Curr Opin Cell Biol. 2008 Apr;20(2):214-21
18329869
J Cell Sci. 2004 Mar 15;117(Pt 8):1351-63
14996912
Nat Rev Cancer. 2007 May;7(5):370-80
17457303
Nature. 1994 Dec 22-29;372(6508):773-6
7997263
Cell. 2002 Sep 20;110(6):673-87
12297042
J Cell Biol. 2004 Mar 15;164(6):935-41
15024036
Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26
15459662
J Biol Chem. 2004 Aug 6;279(32):33139-46
15180997
Cancer Res. 1990 Jul 1;50(13):3872-7
2162246
Am J Respir Cell Mol Biol. 2008 Sep;39(3):364-72
18390474
Carcinogenesis. 1993 May;14(5):833-9
8504475
J Cell Sci. 2005 Mar 15;118(Pt 6):1185-95
15728252
J Cell Sci. 2000 Aug;113 ( Pt 16):2909-21
10910775
J Cutan Pathol. 2001 Mar;28(3):120-6
11168762
J Biol Chem. 2001 Nov 23;276(47):43860-70
11571278
Curr Opin Cell Biol. 2001 Oct;13(5):534-40
11544020
Bioessays. 1990 Feb;12(2):60-6
2140509
J Biol Chem. 2001 Dec 28;276(52):49289-98
11682481
Cancer. 2002 Nov 1;95(9):1902-10
12404284